Vivus (VVUS) -4.7% to $13.65 after receiving a downgrade from Hold to Sell from Brean Capital,...

Vivus (VVUS) -4.7% to $13.65 after receiving a downgrade from Hold to Sell from Brean Capital, which suggests a downside of over 50% on yesterday's close of $14.32 by setting a price target of $7. Brean Capital points out that just one in five patients are covered by insurance for Vivus' Qsymia weight-loss pill, which could lead to "sticker shock" and abandonment.

From other sites
Comments (4)
  • real estate bob
    , contributor
    Comments (120) | Send Message
    Brean Capital - Bet they are short VVUS and have never exceeded the index on their recomendations
    17 Jan 2013, 10:29 AM Reply Like
  • old_fat_and_tired
    , contributor
    Comments (10) | Send Message
    $7 price target seems about right.......... weak sales of Q(unless you consider two weeks free as sales #'s).... no apparent plan to market Stendra(whats up with that) ........ no partner to help with marketing ....... oh wait they can't market ......... only thing propping the PPS is dreams of a buyout and who is going to buy when ....(read above) ... oh and those pesky post approval studies are gonna cost more than the change they can find in the couch or the cars ashtray
    17 Jan 2013, 02:09 PM Reply Like
  • coliwabl
    , contributor
    Comments (26) | Send Message
    Brean Capital is nothing but a scam to drive the price down. They have a reputation for doing whatever they can to drive share price down so they make a bundle with their so-called downgrade. There is absolutely no validity to their statements and reasoning.
    17 Jan 2013, 10:28 PM Reply Like
  • vett777
    , contributor
    Comments (2) | Send Message
    Thank you Brean Capital for the downgrade . I bought 20,000 shares of vvus....
    9 Feb 2013, 11:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs